IT1249706B - Uso di l-carnitina nella gravidanza a rischio. - Google Patents

Uso di l-carnitina nella gravidanza a rischio.

Info

Publication number
IT1249706B
IT1249706B ITRM910695A ITRM910695A IT1249706B IT 1249706 B IT1249706 B IT 1249706B IT RM910695 A ITRM910695 A IT RM910695A IT RM910695 A ITRM910695 A IT RM910695A IT 1249706 B IT1249706 B IT 1249706B
Authority
IT
Italy
Prior art keywords
carnitine
risk
risk pregnancy
pregnancy
fetus
Prior art date
Application number
ITRM910695A
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to ITRM910695A priority Critical patent/IT1249706B/it
Publication of ITRM910695A0 publication Critical patent/ITRM910695A0/it
Priority to EP19920115757 priority patent/EP0535440A3/en
Priority to ZA927100A priority patent/ZA927100B/xx
Priority to JP4249370A priority patent/JPH05194206A/ja
Publication of ITRM910695A1 publication Critical patent/ITRM910695A1/it
Application granted granted Critical
Publication of IT1249706B publication Critical patent/IT1249706B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Viene descritto l'uso della L-carnitina e dei suoi sali farmacologicamente accettabili per preparare una composizione farmaceutica somministrabile per via orale o parenterale, per il trattamento della "gravidanza a rischio" che è presentata da quelle gestanti che, portatrici di malattie ereditarie del metabolismo degli acidi grassi, le trasmettono alla prole con rischio per la sopravvivenza del feto o del neonato.
ITRM910695A 1991-09-18 1991-09-18 Uso di l-carnitina nella gravidanza a rischio. IT1249706B (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITRM910695A IT1249706B (it) 1991-09-18 1991-09-18 Uso di l-carnitina nella gravidanza a rischio.
EP19920115757 EP0535440A3 (en) 1991-09-18 1992-09-15 The use of l-carnitine in endangered pregnancy
ZA927100A ZA927100B (en) 1991-09-18 1992-09-17 The use of L-carnitine in endangered pregnacy.
JP4249370A JPH05194206A (ja) 1991-09-18 1992-09-18 妊娠におけるｌ−カルニチンの使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM910695A IT1249706B (it) 1991-09-18 1991-09-18 Uso di l-carnitina nella gravidanza a rischio.

Publications (3)

Publication Number Publication Date
ITRM910695A0 ITRM910695A0 (it) 1991-09-18
ITRM910695A1 ITRM910695A1 (it) 1993-03-18
IT1249706B true IT1249706B (it) 1995-03-09

Family

ID=11400359

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM910695A IT1249706B (it) 1991-09-18 1991-09-18 Uso di l-carnitina nella gravidanza a rischio.

Country Status (4)

Country Link
EP (1) EP0535440A3 (it)
JP (1) JPH05194206A (it)
IT (1) IT1249706B (it)
ZA (1) ZA927100B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100372341B1 (ko) 1996-12-03 2003-02-17 론자 인코포레이티드 임신기 및 수유기의 돼지를 위한 카르니틴 보충 식이조성물
AU2020236023A1 (en) * 2019-03-14 2021-11-04 Hemoshear Therapeutics, Inc. Methods of treating organic acidemias

Also Published As

Publication number Publication date
EP0535440A3 (en) 1993-08-04
JPH05194206A (ja) 1993-08-03
EP0535440A2 (en) 1993-04-07
ITRM910695A0 (it) 1991-09-18
ZA927100B (en) 1993-03-31
ITRM910695A1 (it) 1993-03-18

Similar Documents

Publication Publication Date Title
Wong et al. Physiologic skin changes in pregnancy
US4654373A (en) Pharmaceutical formulations containing coenzyme Q10 suitable for topic administration
EP1005320B1 (en) Non-irritating composition for treating acne and other skin conditions
DE69100724T2 (de) Zusammensetzungen essentieller Fettsäuren und Therapie.
KR20220044558A (ko) 칸나비디올을 포함하는 외용 제제, 조성물의 제조 방법 및 이의 용도
BR0011640A (pt) ácidos aldÈnicos de oligossacarìdeo e seu uso tópico
MX21218A (es) Procedimiento para preparar una forma de dosificacion farmaceutica para su administracion oral como solido y producto resultante
FR2722098A1 (fr) Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine
ATE225649T1 (de) Arzneizubereitung bestehend aus rhein oder diacerhein mit verbesserter bioverfügbarkeit
CA2096556A1 (en) Fatty acid treatment
US20050272817A1 (en) Dermatological use and a dermatological preparation
JPH04507397A (ja) 湿疹治療用薬剤製造における必須脂肪酸の使用法
KR910005858A (ko) 지방산 요법
HUT73793A (en) Synergetic compositions containing ligands affecting on at least one rxr and at least one rar-alfa receptor
JP2023038290A (ja) ロイシン誘導体、それを含む組成物及びその用途
ZELIGMAN et al. Experimental production of acne by progesterone
IT1252717B (it) Preparato farmaceutico da utilizzare quale trattamento coadiuvante della dermatite seborroica anche in soggetti hiv positivi
Minozzi et al. Odontostomatological approach to the pregnant patient.
Waisman A clinical look at the aging skin
Eriksen et al. Oral retinoic acid as therapy for congenital ichthyosiform erythroderma
DAVIS Long-term estrogen substitution after the menopause
El‐Hefnawi et al. Studies on Pityriasis Versicolor in Egypt: II. Clinical and Therapeutic
DE3280419T2 (de) Medizinisches praeparat zur behandlung von hautleiden.
Richardson et al. Topical androgenic hormones in vulvar kraurosis-leukoplakia syndrome: Preliminary report
Peters et al. Striæ Atrophicæ.? Dyspituitarism

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970709